The company has started to add bearish views on Wall Street as the healthcare giant's business practices draw public scrutiny, risking its prospects, worsened by its recent leadership change. Bank of ...

Novavax, which is licensing the vaccine in ... suggesting this could be the beginning of a broader policy change on COVID vaccines that could also impact Pfizer and Moderna. HHS Communications ...